Meloxicam Market Players:
- Taj Pharmaceutical Limited.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Wellona Pharma
- Trumac Healthcare
- Healthy Life Pharma Private Limited.
- EPICON LIFESCIENCES LLP
- Boehringer Ingelheim GmbH.
- Baudax Bio
- Heron Therapeutics Inc.
- Avanstra Inc.
- PD-Rx Pharmaceuticals, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of meloxicam is evaluated at USD 7.97 billion.
The global meloxicam market size was worth over USD 7.64 billion in 2025 and is poised to grow at a CAGR of around 4.8%, reaching USD 12.21 billion revenue by 2035.
North America meloxicam market is expected to hold a 33% share, attributed to the growing incidence of arthritis and chronic pain disorders.
Key players in the market include Healthy Life Pharma Private Limited., EPICON LIFESCIENCES LLP, Boehringer Ingelheim GmbH., Baudax Bio, Heron Therapeutics Inc., Avanstra Inc., PD-Rx Pharmaceuticals, Inc.
